Shuping Han | Medicine | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Shuping Han | Medicine | Best Researcher Award

Women’s Hospital of Nanjing Medical University | China

Dr. Shuping Han is a distinguished Chief Physician at the Women’s Hospital of Nanjing Medical University, where she also serves as a professor and PhD supervisor. She leads the Department of Pediatrics, focusing on neonatal medicine and maternal-child healthcare. With extensive clinical and research experience, she has contributed significantly to neonatology, particularly in preterm care and neonatal diseases. Dr. Han has trained numerous physicians and pioneered innovative medical practices, earning recognition as a leader in her field.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Outstanding Research Contributions – Dr. Han has led multiple impactful research projects, including those on neonatal diseases, human milk research, and preterm infant care. Her work on NEC prevention and neonatal hyperbilirubinemia has resulted in significant clinical advancements.

  • High Research Output – With 35 SCI/Scopus-indexed journal publications, books, and patents, she has established a strong research profile.

  • National and International Recognition – Her research has been recognized with prestigious awards such as the Jiangsu Medical Science and Technology Award and the National Maternal and Child Health Science and Technology Award (2023).

  • Clinical Impact – Her work has led to real-world applications, such as reducing NEC incidence and influencing national healthcare guidelines.

  • Leadership and Collaboration – She holds key positions in professional organizations, editorial boards, and multidisciplinary collaborations, showing her influence in the field.

Education 🎓

Dr. Han obtained her Doctor of Pediatrics degree and pursued further studies at top medical institutions, including the Children’s Hospital of Fudan University (Shanghai), Denver Children’s Hospital (University of Colorado, USA), and Philadelphia Children’s Hospital (University of Pennsylvania, USA). Her academic journey has equipped her with cutting-edge knowledge and skills in neonatal and pediatric medicine.

Experience 💼

With decades of experience, Dr. Han is the Administrative Director of the Department of Pediatrics at the Obstetrics and Gynecology Hospital affiliated with Nanjing Medical University. She has led key neonatal healthcare initiatives and played an instrumental role in establishing Jiangsu Provincial Key Clinical Specialty in Neonatology. Her leadership has contributed to advancements in neonatal disease diagnosis and treatment.

Research Interests On Medicine 🌍

Dr. Han’s research focuses on preterm-related diseases, human milk studies, and neonatal hyperbilirubinemia. Her work explores necrotizing enterocolitis (NEC) and bronchopulmonary dysplasia (BPD), aiming to develop innovative prevention strategies. She has conducted multi-center studies on severe complications in preterm infants and the protective effects of human milk-derived peptides, advancing neonatal healthcare globally.

Awards 🏆

Dr. Han’s contributions have earned her prestigious accolades, including:

  • Jiangsu Medical Science and Technology Award (2023)
  • National Maternal and Child Health Science and Technology Award (2023) Her groundbreaking research and dedication to neonatal care have positioned her as a leading expert in the field.

Publications 📚

Dr. Han has authored over 35 papers in SCI/Scopus-indexed journals. Some of her notable publications include:

  1. Effect of probiotics on necrotizing enterocolitis in preterm infants: a network meta-analysis of randomized controlled trials

    • Authors: Y. Dai, Q. Yu, F. Zhang, S. Li, S. Han

    • Publication Year: 2025

  2. Association between antenatal corticosteroids and neonatal outcomes among very preterm infants born to mothers with hypertensive disorders of pregnancy: a multicenter cohort study

    • Authors: M. Sun, A. Qian, X. Li, T. Yang, L. Yuan

    • Publication Year: 2025

  3. The current clinical landscape of preterm infants less than 32 weeks of gestation receiving delivery room chest compression in Jiangsu Province, China

    • Authors: N. Wang, W. Hou, H. Zhou, J. Zhang, R. Cheng

    • Publication Year: 2025

  4. Risk factors and adverse outcomes of initial non-invasive ventilation failure in very low birth weight infants: a multicenter retrospective cohort study

    • Authors: J. Zhu, S. Li, Y. Gao, S. Han

    • Publication Year: 2024

  5. Conjugated linoleic acid ameliorates necrotizing enterocolitis by suppressing inflammatory responses and maintaining intestinal barrier integrity via the PPARγ/NFκB signaling pathway

    • Authors: C. Jiang, F. Zhang, M. Zhang, S. Li, S. Han

    • Publication Year: 2024

  6. Association of neonatal outcome with birth weight for gestational age in Chinese very preterm infants: a retrospective cohort study

    • Authors: L. Li, J. Guo, Y. Wang, W. Zhou, L. Du

    • Publication Year: 2024

  7. RBC transfusion and necrotizing enterocolitis in very preterm infants: a multicenter observational study

    • Authors: D. Dang, X. Gu, S. Jiang, Y. Wu, J.Y. Ting

    • Publication Year: 2024

  8. The performance of the practices associated with the occurrence of severe intraventricular hemorrhage in the very premature infants: data analysis from the Chinese neonatal network

    • Authors: T. Xiao, L. Hu, H. Chen, Y. Chen, Y. Wu

    • Publication Year: 2024

  9. Using a new human milk fortifier to optimize human milk feeding among very preterm and/or very low birth weight infants: a multicenter study in China

    • Authors: J. Han, L. Zhang, R. Zhang, C. Liu, Y. Cao

    • Publication Year: 2024

  10. Neonatal lupus erythematosus with severe persistent pulmonary hypertension

  • Authors: B. Zhuang, Y. Chen, S. Han

  • Publication Year: 2024

Conclusion 📄

Dr. Shuping Han’s exemplary career in neonatology has made a profound impact on neonatal care and maternal-child health. Through her research, leadership, and clinical expertise, she has improved preterm infant outcomes and influenced healthcare policies. Her dedication to innovation and mentorship continues to shape the future of neonatal medicine, solidifying her reputation as a pioneer in the field.

Yang Li | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Yang Li | Medicine | Best Researcher Award

Shanghai East Hospital, Tongji University School of Medicine | China

Dr. Yang Li is a dedicated postdoctoral researcher at Shanghai East Hospital, affiliated with the Tongji University School of Medicine. With a strong background in internal medicine, he has actively contributed to medical research and patient care. His academic journey is marked by significant achievements, and his work continues to impact the field of clinical medicine, particularly in the areas of metabolic disorders and geriatric health.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background

    • Yang Li has a well-structured academic trajectory, progressing from a Bachelor’s degree in Clinical Medicine to a Postdoctoral position at a reputable institution (Shanghai East Hospital, Tongji University School of Medicine).

    • The M.D. in Internal Medicine and a prior Master’s degree provide a solid foundation for research in this field.

  • Impressive Publication Record

    • Multiple first-author publications in well-regarded medical journals, indicating independent research contributions.

    • Publications focus on crucial areas such as metabolic diseases, multimorbidity, and nephroprotection, showcasing a diverse yet specialized research profile.

    • Collaboration with multidisciplinary teams suggests strong teamwork and networking in the research community.

  • Impactful Research Topics

    • The studies address real-world clinical challenges, including lipid metabolism, diabetes, multimorbidity, and nephroprotection, which have significant implications for patient care.

    • The use of large-scale datasets and real-world analysis enhances the credibility and applicability of findings.

  • Consistency and Productivity

    • Continuous output of publications from 2022 to 2025 demonstrates a sustained research commitment.

    • The ability to conduct retrospective cohort studies and cross-sectional analyses highlights strong methodological expertise.

Education 🎓

Yang Li pursued his higher education at Tongji University, where he earned multiple degrees in clinical and internal medicine:

  • M.D. in Internal Medicine (2020-2023)
  • Master’s Degree in Internal Medicine (2017-2019)
  • Bachelor’s Degree in Clinical Medicine (2011-2017) His academic training has equipped him with in-depth knowledge and expertise in diagnosing and treating complex medical conditions.

Experience 🎉

As a postdoctoral researcher at Shanghai East Hospital, Yang Li has been deeply involved in clinical research, focusing on metabolic health, multimorbidity, and geriatric care. His work bridges the gap between clinical practice and research, aiming to improve patient outcomes through evidence-based findings. His experience spans retrospective cohort studies, cross-sectional analyses, and real-world population-based research.

Research Interest On Medicine 🔬

Yang Li’s research interests include:

  • Metabolic Disorders & Insulin Resistance
  • Geriatric Multimorbidity and Critical Care
  • Cardiometabolic Health & Lifestyle Factors
  • Pharmacological Interventions in Diabetes Management Through his research, he seeks to understand the intricate relationships between metabolic health, aging, and disease prevention.

Awards 🏆

Yang Li has received recognition for his significant contributions to medical research. His work has been acknowledged in the form of grants, academic awards, and invitations to present at international conferences. His research excellence continues to earn him accolades in the scientific community.

Publications 📚

Yang Li has authored multiple impactful publications in peer-reviewed journals. Some of his notable works include:

  • “Sex differences in associations of metabolic inflammation and insulin resistance with incident type 2 diabetes mellitus: a retrospective cohort of adults with annual health examinations”

    • Authors: Yang Li, Xiaotong Guo, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Huixiao Yuan, Shasha Geng, Yue Liu​

    • Publication Year: 2025​

  • “Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data”

    • Authors: Yang Li, Shasha Geng, Huixiao Yuan, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Yue Liu, Xiaotong Guo, Xiaoli Wang, et al.​

    • Publication Year: 2024​

  • “Nephroprotective effect of SGLT2 inhibitors in elderly patients with type 2 diabetes mellitus and hypertension: a real-world population-based cohort study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Yue Liu, Qingqing Li, Xin Chen, Yingqian Zhu, Xiaotong Guo, Huixiao Yuan, Xiaoli Wang, et al.​

    • Publication Date: November 16, 2024​

  • “Global trends in research related to functional dyspepsia and anxiety or depression over the past two decades: a bibliometric analysis”

    • Authors: Qian Huang, Huixiao Yuan, Qingqing Li, Yang Li, Shasha Geng, Yingqian Zhu, Min Liao, Hua Jiang​

    • Publication Year: 2023​

  • “Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia”

    • Authors: Yingqian Zhu, Xin Chen, Shasha Geng, Qingqing Li, Yang Li, Huixiao Yuan, Hua Jiang​

    • Publication Year: 2023​

  • “Reliability of Risk Assessment for Intra-Hospital Venous Thromboembolism: An Exploratory Cross-Sectional Study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Xiaotong Guo, Yue Liu, Hua Jiang​

    • Publication Year: 2023​

  • “Lifestyle-based oxidative balance score and its association with cardiometabolic health of the community-dwelling elderly: A cross-sectional secondary analysis”

    • Authors: Yang Li, Huixiao Yuan, Qingqing Li, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: September 27, 2022​

  • “Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: December 2019​

  • “Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: July 11, 2019​

Conclusion 🏅

Yang Li is an accomplished medical researcher whose work contributes significantly to the field of internal medicine. His dedication to advancing medical knowledge, combined with his expertise in metabolic and geriatric health, underscores his role as a leading researcher in his field. Through his publications and ongoing research, he continues to impact patient care and medical science positively.